Your browser doesn't support javascript.
loading
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization.
Werr, Lisa; Plenker, Dennis; Dammert, Marcel A; Lorenz, Carina; Brägelmann, Johannes; Tumbrink, Hannah L; Klein, Sebastian; Schmitt, Anna; Büttner, Reinhard; Persigehl, Thorsten; Shokat, Kevan M; Wunderlich, F Thomas; Schram, Alison M; Peifer, Martin; Sos, Martin L; Reinhardt, H Christian; Thomas, Roman K.
Afiliação
  • Werr L; Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Plenker D; Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Dammert MA; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Lorenz C; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Brägelmann J; Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Tumbrink HL; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Klein S; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Schmitt A; Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Büttner R; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Persigehl T; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Shokat KM; Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Wunderlich FT; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Schram AM; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Peifer M; Mildred Scheel School of Oncology, Cologne, University Hospital Cologne, Medical Faculty, Cologne, Germany.
  • Sos ML; Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Reinhardt HC; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
  • Thomas RK; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Mol Cancer Ther ; 21(5): 821-830, 2022 05 04.
Article em En | MEDLINE | ID: mdl-35247925
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article